+44 (0) 113 206 7735 Email us

Skip to navigation

Lung Cancer

There are two main types of primary lung cancer which behave and respond to treatment differently.

Non-small cell lung cancer is the most common type of lung cancer and accounts for 85% of cases. It has a number of variants and can be treated with surgery, chemotherapy, radiotherapy or a combination of all three.

Small cell lung cancer is most commonly found in smokers and is usually treated with chemotherapy, or a combination of chemotherapy and radiotherapy.

Nova Healthcare offers chemotherapy, targeted therapies and radiotherapy for the treatment of lung cancer and, in partnership with Leeds Cancer Centre, was the first centre in the UK to treat primary lung cancer with stereotactic ablative radiotherapy (SABR).

SABR is a non-invasive, advanced radiotherapy technique that delivers high doses of intensely focused radiation to the tumour over a small number of outpatient treatments.

Further information about lung cancer can be accessed through the Macmillan Cancer Care website or by downloading the booklet to the right.

Consultants specialising in the treatment of lung cancer

Dr. Peter Dickinson

Consultant Clinical Oncologist

Macmillan Cancer Care factsheets

Understanding Lung Cancer

Back to top

Nova Healthcare is part of Aspen Healthcare Group. Registered Office: Centurion House, 37 Jewry Street, London, EC3N 2ER. T: 020 7977 6080 E: info@aspen-healthcare.co.uk